Thermo Fisher Scientific Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $31.07B | $49.58B | $4.01B |
| FY2025 | $39.17B | $53.41B | $9.85B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $31.07B | $49.58B | $4.01B |
| FY2025 | $39.17B | $53.41B | $9.85B |